Zdrowie i gospodarka · 21/05/2025
FDA Announces Draft Guidance on Roflumilast
The FDA is releasing a new draft guidance for industry on roflumilast, which will provide product-specific recommendations for bioequivalence studies to support ANDA applications for the topical cream.